Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 3/2010

01.12.2010 | Research Report

Social-adaptive and psychological functioning of patients affected by Fabry disease

verfasst von: Dawn Alyssia Laney, Daniel J. Gruskin, Paul M. Fernhoff, Joseph F. Cubells, Opal Y. Ousley, Heather Hipp, Ami J. Mehta

Erschienen in: Journal of Inherited Metabolic Disease | Sonderheft 3/2010

Einloggen, um Zugang zu erhalten

Summary

Fabry disease (FD) is an X-linked lysosomal storage disorder caused by the deficiency of alpha-galactosidase A. In addition to the debilitating physical symptoms of FD, there are also under-recognized and poorly characterized psychiatric features. As a first step toward characterizing psychiatric features of FD, we administered the Achenbach adult self report questionnaire to 30 FD patients and the Achenbach adult behavior checklist questionnaire to 28 partners/parents/friends of FD patients. Data from at least one of the questionnaires were available on 33 subjects. Analysis focused on social-adaptive functioning in various aspects of daily life and on criteria related to the Diagnostic and statistical manual of mental disorders IV (DSM-IV). Adaptive functioning scale values, which primarily measure social and relationship functioning and occupational success, showed that eight FD patients (six female and two male) had mean adaptive functioning deficits as compared to population norms. Greater rates of depression (P < 0.01), anxiety (P = 0.05), depression and anxiety (P = 0.03), antisocial personality (P < 0.001), attention-deficit/hyperactivity (AD/H; P < 0.01), hyperactivity–impulsivity (P < 0.01), and aggressive behavior (P = 0.03) were associated with poorer adaptive functioning. Decreased social-adaptive functioning in this study was not statistically significantly associated to disease severity, pain, or level of vitality. This study shows for the first time that FD patients, particularly women, are affected by decreased social-adaptive functioning. Comprehensive treatment plans for FD should consider assessments and interventions to evaluate and improve social, occupational, and psychological functioning. Attention to the behavioral aspects of FD could lead to improved treatment outcome and improved quality of life. Individuals affected by Fabry disease exhibited social-adaptive functioning deficits that were significantly correlated with anxiety, depression, antisocial behavior, and AD/H problems in a sampling of our male and female patients aged between 18 years and 59 years.
Literatur
Zurück zum Zitat Achenbach TM, Rescorla LA (2003) Manual for the ASEBA adult forms and profiles. University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT, www.aseba.org Achenbach TM, Rescorla LA (2003) Manual for the ASEBA adult forms and profiles. University of Vermont, Research Center for Children, Youth, and Families, Burlington, VT, www.​aseba.​org
Zurück zum Zitat Achenbach TM, Bernstein A, Dumenci L (2005) DSM-oriented scales and statistically based syndromes for ages 18 to 59: Linking taxonomic paradigms to facilitate multitaxonomic approaches. J Pers Assess 84:49–63PubMedCrossRef Achenbach TM, Bernstein A, Dumenci L (2005) DSM-oriented scales and statistically based syndromes for ages 18 to 59: Linking taxonomic paradigms to facilitate multitaxonomic approaches. J Pers Assess 84:49–63PubMedCrossRef
Zurück zum Zitat Beck M (2006) The Mainz severity score index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95:43–46PubMedCrossRef Beck M (2006) The Mainz severity score index (MSSI): development and validation of a system for scoring the signs and symptoms of Fabry disease. Acta Paediatr Suppl 95:43–46PubMedCrossRef
Zurück zum Zitat Berenbaum SA, Bryk KK, Duck SC, Resnick SM (2004) Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 144:741–746PubMed Berenbaum SA, Bryk KK, Duck SC, Resnick SM (2004) Psychological adjustment in children and adults with congenital adrenal hyperplasia. J Pediatr 144:741–746PubMed
Zurück zum Zitat Brady R, Grabowski GA, Thadhani R (2001) Fabry disease: Review and new perspective. SynerMed Communications 1:1–8 Brady R, Grabowski GA, Thadhani R (2001) Fabry disease: Review and new perspective. SynerMed Communications 1:1–8
Zurück zum Zitat Buysse CM, Raat H, Hazelzet JA et al (2007) Long-term psychosocial outcomes in survivors of meningococcal septic shock in childhood, and in their parents. Qual Life Res 16:1567–1576PubMedCrossRef Buysse CM, Raat H, Hazelzet JA et al (2007) Long-term psychosocial outcomes in survivors of meningococcal septic shock in childhood, and in their parents. Qual Life Res 16:1567–1576PubMedCrossRef
Zurück zum Zitat Carpenter RE, Loo SK, Yang M, Dang J, Smalley SL (2009) Social functioning difficulties in ADHD: association with PDD risk. Clin Child Psychol Psychiatry 14:329–344CrossRef Carpenter RE, Loo SK, Yang M, Dang J, Smalley SL (2009) Social functioning difficulties in ADHD: association with PDD risk. Clin Child Psychol Psychiatry 14:329–344CrossRef
Zurück zum Zitat Cleeland CS (2002) Pain assessment: the advantages of using pain scales in lysosomal storage diseases. Acta Paediatr Suppl 91:43–47PubMedCrossRef Cleeland CS (2002) Pain assessment: the advantages of using pain scales in lysosomal storage diseases. Acta Paediatr Suppl 91:43–47PubMedCrossRef
Zurück zum Zitat Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138PubMed Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129–138PubMed
Zurück zum Zitat Cole A, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30:943–951PubMedCrossRef Cole A, Lee PJ, Hughes DA, Deegan PB, Waldek S, Lachmann RH (2007) Depression in adults with Fabry disease: a common and under-diagnosed problem. J Inherit Metab Dis 30:943–951PubMedCrossRef
Zurück zum Zitat Compas BE, Boyer MC, Stanger C et al (2006) Latent variable analysis of coping, anxiety/depression, and somatic symptoms in adolescents with chronic pain. J Consult Clin Psychol 74:1132–1142PubMedCrossRef Compas BE, Boyer MC, Stanger C et al (2006) Latent variable analysis of coping, anxiety/depression, and somatic symptoms in adolescents with chronic pain. J Consult Clin Psychol 74:1132–1142PubMedCrossRef
Zurück zum Zitat Cubells JF (2007) Beyond irritability and aggressive behavior: does risperidone improve adaptive behavior in autistic spectrum disorders? Curr Psychiatry Rep 9:132–133PubMed Cubells JF (2007) Beyond irritability and aggressive behavior: does risperidone improve adaptive behavior in autistic spectrum disorders? Curr Psychiatry Rep 9:132–133PubMed
Zurück zum Zitat Desnick R, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346PubMedCrossRef Desnick R, Brady R, Barranger J et al (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338–346PubMedCrossRef
Zurück zum Zitat Gold K, Pastores GM, Botteman MF et al (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317–327PubMedCrossRef Gold K, Pastores GM, Botteman MF et al (2002) Quality of life of patients with Fabry disease. Qual Life Res 11:317–327PubMedCrossRef
Zurück zum Zitat Gothelf D, Feinstein C, Thompson T et al (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164:663–669PubMedCrossRef Gothelf D, Feinstein C, Thompson T et al (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11.2 deletion syndrome. Am J Psychiatry 164:663–669PubMedCrossRef
Zurück zum Zitat Gray D, Parker-Cohen NY, White T, Clark ST, Seiner SHAJ, McMahon WM (2001) A comparison of individual and family psychology of adolescents with chronic fatigue syndrome, rheumatoid arthritis, and mood disorders. J Dev Behav Pediatr 22:234–242PubMedCrossRef Gray D, Parker-Cohen NY, White T, Clark ST, Seiner SHAJ, McMahon WM (2001) A comparison of individual and family psychology of adolescents with chronic fatigue syndrome, rheumatoid arthritis, and mood disorders. J Dev Behav Pediatr 22:234–242PubMedCrossRef
Zurück zum Zitat Grewal R (1993) Psychiatric disorders in patients with Fabry disease. Int J Psychiatry Med 23:308–312CrossRef Grewal R (1993) Psychiatric disorders in patients with Fabry disease. Int J Psychiatry Med 23:308–312CrossRef
Zurück zum Zitat Hack M, Youngstrom EA, Cartar L et al (2004) Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 114:932–940PubMedCrossRef Hack M, Youngstrom EA, Cartar L et al (2004) Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 114:932–940PubMedCrossRef
Zurück zum Zitat Hinton VJ, Nereo NE, Fee RJ, Cyrulnik SE (2006) Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr 27:470–476PubMedCrossRef Hinton VJ, Nereo NE, Fee RJ, Cyrulnik SE (2006) Social behavior problems in boys with Duchenne muscular dystrophy. J Dev Behav Pediatr 27:470–476PubMedCrossRef
Zurück zum Zitat Hoffman B, Garcia de Lorenzo A, Mehta A et al (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet 42:247–252CrossRef Hoffman B, Garcia de Lorenzo A, Mehta A et al (2005) Effects of enzyme replacement therapy on pain and health related quality of life in patients with Fabry disease: data from FOS (Fabry Outcome Survey). J Med Genet 42:247–252CrossRef
Zurück zum Zitat Hoffman B, Beck M, Sunder Plassman G et al (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy—a retrospective analysis from the Fabry outcome survey. Clin J Pain 23:535–542CrossRef Hoffman B, Beck M, Sunder Plassman G et al (2007) Nature and prevalence of pain in Fabry disease and its response to enzyme replacement therapy—a retrospective analysis from the Fabry outcome survey. Clin J Pain 23:535–542CrossRef
Zurück zum Zitat Howe GW, Feinstein C, Reiss D, Molock S, Berger K (1993) Adolescent adjustment to chronic physical disorders: I. Comparing neurological and non-neurological conditions. J Child Psychol Psychiatry 34:1153–1171PubMedCrossRef Howe GW, Feinstein C, Reiss D, Molock S, Berger K (1993) Adolescent adjustment to chronic physical disorders: I. Comparing neurological and non-neurological conditions. J Child Psychol Psychiatry 34:1153–1171PubMedCrossRef
Zurück zum Zitat Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ (2002) The heart in Anderson Fabry disease. Z Kardiol 91:786–795PubMedCrossRef Kampmann C, Wiethoff CM, Perrot A, Beck M, Dietz R, Osterziel KJ (2002) The heart in Anderson Fabry disease. Z Kardiol 91:786–795PubMedCrossRef
Zurück zum Zitat Katon W, Russo J, Lin EH et al (2009) Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 50:570–579 Katon W, Russo J, Lin EH et al (2009) Diabetes and poor disease control: is comorbid depression associated with poor medication adherence or lack of treatment intensification? Psychosom Med 50:570–579
Zurück zum Zitat Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont) 6:38–51 Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE (2009) Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry (Edgmont) 6:38–51
Zurück zum Zitat MacDermot K, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769–775PubMedCrossRef MacDermot K, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769–775PubMedCrossRef
Zurück zum Zitat Miners A, Holmes A, Sherr L et al (2002) Assessment of health-related quality-of-life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127–133PubMedCrossRef Miners A, Holmes A, Sherr L et al (2002) Assessment of health-related quality-of-life in males with Anderson Fabry disease before therapeutic intervention. Qual Life Res 11:127–133PubMedCrossRef
Zurück zum Zitat Muller M, Muller KM, Dascalescu A et al (2005) Psychiatric and neuropsychological signs and symptoms in patients with Fabry disease: literature review. Fortschr Neurol Psychiatr 73:687–693PubMedCrossRef Muller M, Muller KM, Dascalescu A et al (2005) Psychiatric and neuropsychological signs and symptoms in patients with Fabry disease: literature review. Fortschr Neurol Psychiatr 73:687–693PubMedCrossRef
Zurück zum Zitat Mureau MAM, Slijper FME, Slob AK, Verhulst FC (1997) Psychosocial functioning of children, adolescents, and adults following hypospadias surgery: a comparative study. J Pediatr Psychol 22:371–387PubMedCrossRef Mureau MAM, Slijper FME, Slob AK, Verhulst FC (1997) Psychosocial functioning of children, adolescents, and adults following hypospadias surgery: a comparative study. J Pediatr Psychol 22:371–387PubMedCrossRef
Zurück zum Zitat RADAR (2009) The Fabry Registry Aggregate Data Annual Report (RADAR). Fabry registry. Genzyme Corporation, Boston, MA RADAR (2009) The Fabry Registry Aggregate Data Annual Report (RADAR). Fabry registry. Genzyme Corporation, Boston, MA
Zurück zum Zitat Roza SJ, Hofstra MB, van der Ende J, Verhulst FC (2003) Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood. Am J Psychiatry 160:2116–2121PubMedCrossRef Roza SJ, Hofstra MB, van der Ende J, Verhulst FC (2003) Stable prediction of mood and anxiety disorders based on behavioral and emotional problems in childhood: a 14-year follow-up during childhood, adolescence, and young adulthood. Am J Psychiatry 160:2116–2121PubMedCrossRef
Zurück zum Zitat Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201PubMedCrossRef Sadek J, Shellhaas R, Camfield CS, Camfield PR, Burley J (2004) Psychiatric findings in four female carriers of Fabry disease. Psychiatr Genet 14:199–201PubMedCrossRef
Zurück zum Zitat Sbarra DA, Rimm-Kaufman SE, Pianta RC (2002) The behavioral and emotional correlates of epilepsy in adolescence: a 7-year follow-up. Epilepsy Behav 3:358–367PubMedCrossRef Sbarra DA, Rimm-Kaufman SE, Pianta RC (2002) The behavioral and emotional correlates of epilepsy in adolescence: a 7-year follow-up. Epilepsy Behav 3:358–367PubMedCrossRef
Zurück zum Zitat Schiffmann R, Scott LJ (2002) Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl 91:48–52PubMedCrossRef Schiffmann R, Scott LJ (2002) Pathophysiology and assessment of neuropathic pain in Fabry disease. Acta Paediatr Suppl 91:48–52PubMedCrossRef
Zurück zum Zitat Stavro GM, Ettenhofer ML, Nigg JT (2007) Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc 13:324–334PubMedCrossRef Stavro GM, Ettenhofer ML, Nigg JT (2007) Executive functions and adaptive functioning in young adult attention-deficit/hyperactivity disorder. J Int Neuropsychol Soc 13:324–334PubMedCrossRef
Zurück zum Zitat Street N, Yi MS, Bailey LA, Hopkin RJ (2006) Comparison of health related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med 8:346–353PubMedCrossRef Street N, Yi MS, Bailey LA, Hopkin RJ (2006) Comparison of health related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease. Genet Med 8:346–353PubMedCrossRef
Zurück zum Zitat Todd RD, Huang H, Todorov AA, Neuman RJ, Reiersen AM, Henderson CA, Reich WC (2008) Predictors of stability of attention-deficit/hyperactivity disorder subtypes from childhood to young adulthood. J Am Acad Child Adolesc Psychiatry 47:76–85PubMedCrossRef Todd RD, Huang H, Todorov AA, Neuman RJ, Reiersen AM, Henderson CA, Reich WC (2008) Predictors of stability of attention-deficit/hyperactivity disorder subtypes from childhood to young adulthood. J Am Acad Child Adolesc Psychiatry 47:76–85PubMedCrossRef
Zurück zum Zitat van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2007) Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study. Psychol Med 37:1635–1644PubMed van Grootheest DS, Cath DC, Beekman AT, Boomsma DI (2007) Genetic and environmental influences on obsessive-compulsive symptoms in adults: a population-based twin-family study. Psychol Med 37:1635–1644PubMed
Zurück zum Zitat van Pareren YK, Duivenvoorden HJ, Slijper FME et al (2005) Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm Res 63:238–244 van Pareren YK, Duivenvoorden HJ, Slijper FME et al (2005) Psychosocial functioning after discontinuation of long-term growth hormone treatment in girls with Turner syndrome. Horm Res 63:238–244
Zurück zum Zitat van Rijen EHM, Utens EMWJ, Roos-Hesselink JW et al (2004) Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 25:1605–1613PubMedCrossRef van Rijen EHM, Utens EMWJ, Roos-Hesselink JW et al (2004) Medical predictors for psychopathology in adults with operated congenital heart disease. Eur Heart J 25:1605–1613PubMedCrossRef
Zurück zum Zitat Väistö T, Aronen ET, Simola P, Ashorn M, Kolho KL (2009) Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis 16:27–35 Väistö T, Aronen ET, Simola P, Ashorn M, Kolho KL (2009) Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis 16:27–35
Zurück zum Zitat Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34–45 Wang RY, Lelis A, Mirocha J, Wilcox WR (2007) Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet Med 9:34–45
Zurück zum Zitat West M, LeMoine K (2007) Withdrawal of enzyme replacement therapy in Fabry disease: indirect evidence of treatment benefit? Mol Genet Metab 92:32CrossRef West M, LeMoine K (2007) Withdrawal of enzyme replacement therapy in Fabry disease: indirect evidence of treatment benefit? Mol Genet Metab 92:32CrossRef
Zurück zum Zitat Whybra C, Kampmann C, Krummenauer F et al (2004) The Mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299–307PubMedCrossRef Whybra C, Kampmann C, Krummenauer F et al (2004) The Mainz severity score index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy. Clin Genet 65:299–307PubMedCrossRef
Zurück zum Zitat Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112–128PubMedCrossRef Wilcox WR, Oliveira JP, Hopkin RJ et al (2008) Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab 93:112–128PubMedCrossRef
Metadaten
Titel
Social-adaptive and psychological functioning of patients affected by Fabry disease
verfasst von
Dawn Alyssia Laney
Daniel J. Gruskin
Paul M. Fernhoff
Joseph F. Cubells
Opal Y. Ousley
Heather Hipp
Ami J. Mehta
Publikationsdatum
01.12.2010
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe Sonderheft 3/2010
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-9025-6

Weitere Artikel der Sonderheft 3/2010

Journal of Inherited Metabolic Disease 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.